Skin boosters: the category explained for clinics

“Skin boosters” has become the umbrella term patients use for almost any injectable that is not toxin or filler, which makes it one of the most useful and most muddled phrases in the consultation room. This guide gives practitioners a clean map of the category: what skin boosters actually are, where products like Profhilo and polynucleotides sit relative to them, how courses typically run, who to treat, and the consent and record-keeping standard that applies across all of it. If your patients arrive asking for “a skin booster”, this is the structure for the conversation that follows.

What skin boosters are

Skin boosters are microinjections of hydrating products, classically soft, lightly cross-linked or non-cross-linked hyaluronic acid, placed superficially in the skin across the treatment area. Unlike dermal filler, the product is not there to hold shape or add volume; it is there to bind water within the skin, improving hydration, glow, fine crepiness and overall skin condition. Many modern formulations add ingredients such as amino acids or vitamins, and the category now stretches from simple HA preparations to more complex injectable moisturisers.

The defining characteristics are the placement (superficial, spread across an area in many small deposits) and the goal (skin quality rather than structure). Common areas are the face, neck, décolletage and hands, and the typical patient-visible result is skin that looks better hydrated, smoother and healthier rather than visibly changed in shape.

Where Profhilo and polynucleotides fit

Patients and marketing materials often file everything in this space under “skin boosters”, so it is worth being precise about the two best-known neighbours.

Profhilo is usually described as a bio-remodelling treatment rather than a classic skin booster. It is a high-concentration, thermally stabilised hyaluronic acid delivered at a small number of defined points (the BAP technique, five per side of the face) rather than as many microinjections, and it runs as a fixed two-session protocol four weeks apart. It targets laxity as well as hydration. Our Profhilo guide covers it in full.

Polynucleotides are not hyaluronic acid at all: they are purified DNA-fragment injectables, commonly salmon-derived, positioned as regenerative. The aim is to stimulate the skin’s own repair processes over a course of two to three sessions, and they are often chosen for the under-eye area and thin or damaged skin. Our polynucleotides guide covers them in detail.

A practical way to present the category in consultation: classic skin boosters hydrate, Profhilo hydrates and addresses laxity, polynucleotides regenerate. The boundaries are softer than that in reality, and plenty of patients do well on any of the three, but the framing helps a patient understand why you are recommending one over another for their skin.

Typical courses

Classic skin boosters almost always run as a course, commonly two to three sessions spaced two to four weeks apart, followed by maintenance sessions every several months. Results build across the course and are judged after it finishes, not after the first session. Protocols, dosing and recommended intervals vary considerably between products, so check the manufacturer’s guidance for the specific product you use and build your booking and pricing structure around the full course. Single-session pricing that quietly assumes the patient will return is how courses fall apart; book the series at the outset and say plainly that one session is an incomplete treatment.

Patient selection

Good candidates are patients whose concern is skin condition: dehydration, dullness, fine crepiness, early texture change, smokers’ skin, sun-exposed necks and hands. Skin boosters suit patients who want their skin to look better without anything looking done, and they are a sensible first injectable for patients wary of filler. They are the wrong recommendation where the real concern is volume loss, deep folds or significant laxity, where they may play a supporting role but will not deliver the change the patient is picturing.

Standard exclusions apply: pregnancy and breastfeeding, active skin infection or inflammation in the treatment area, known allergy to any component of the chosen product, and, for salmon-derived polynucleotides specifically, fish allergy. Screen in writing rather than conversationally, and re-consult rather than treat any patient whose expectations do not match what the category can do.

Records and consent

Because “skin boosters” covers many different products, the consent and the treatment record have to name the specifics: the exact product, the batch number and expiry, the areas treated, the volume used and the technique. A generic “skin booster session” entry in the diary is not a treatment record. Batch-level recording is what makes a manufacturer recall manageable and is part of the documentation baseline England’s planned licensing scheme is expected to formalise; our licensing-ready records checklist sets out the full standard.

Consent should itemise the recognised risks (injection-site reactions, bumps, bruising, swelling, infection, allergy, and rare vascular events), name the course structure, and make clear that results are gradual and cannot be guaranteed. Our skin booster consent form template is a ready starting point, and written aftercare should follow every session; our skin booster aftercare sheet is built to copy. The wider guides library covers the rest of the compliance picture.

Keeping a course-based menu manageable

A skin-booster menu multiplies paperwork: every product needs its own consent wording, every session its own record and aftercare, and every course its sequence of bookings. AesthetiClinic runs that as one workflow, with versioned e-signed consent per treatment, batch numbers captured on each record and aftercare sent automatically after every visit. See how it works on the features page.